Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds